Skip to main content

Table 3 Characteristics of the respondents, per country

From: Predictors for patient knowledge and reported behaviour regarding driving under the influence of medicines: a multi-country survey

 

Country

p-value*

 

Belgium

Germany

Netherlands

Spain

 

Total number of participants

136

146

136

215

 
 

n

%a

n

%a

n

%a

n

%a

 

Gender

         

   Male

135

34.6

145

34.2

136

41.2

214

47.0

0.175

   Female

 

64.7

 

65.1

 

58.8

 

52.6

 

Age Category

         

   18-25

 

5.9

 

1.4

 

3.7

 

6.5

 

   26-34

134

11.8

145

10.3

136

5.9

213

20.5

< 0.001*

   35-44

 

18.4

 

24.7

 

26.5

 

27.0

 

   45-54

 

32.4

 

21.2

 

23.5

 

22.8

 

   55-64

 

15.4

 

19.2

 

27.2

 

14.0

 

   65-75

 

14.7

 

22.6

 

13.2

 

8.4

 

Educational level

         

   Not completed primary education

 

11.0

 

0.7

 

1.5

 

5.1

 

   Completed primary education

 

14.7

 

32.2

 

5.9

 

19.1

 

   Lower vocational training

132

22.8

145

32.2

128

19.1

215

16.7

< 0.001*

   Intermediate vocational training

 

25.7

 

17.8

 

41.9

 

19.5

 

   University

 

22.8

 

16.4

 

25.7

 

39.5

 

Use of motorised vehicles

         

   Sporadic users

136

33.1

146

34.9

136

47.8

215

31.2

0.012*

   Frequent users

 

66.9

 

65.1

 

52.2

 

68.8

 

Use of driving-impairing medicines

         

   Use of 1 medicine

 

65.2

 

70.8

 

71.2

 

75.0

 

   Use of 2 medicines

 

28.1

 

25.0

 

23.5

 

21.2

 

   Use of 3 medicines

135

5.9

144

4.2

132

4.5

212

2.8

0.734

   Use of 4 medicines

 

0.7

 

0.0

 

0.8

 

0.9

 

Experienced side effects

         

   No

132

51.5

146

48.6

134

37.3

211

29.9

< 0.001*

   Yes

 

48.5

 

51.4

 

62.7

 

70.1

 

Knowledge b

         

   About the risk of having a road accident when using medicinesc

2.4 (1.0)

2.4 (1.1)

2.3 (1.0)

2.3 (0.9)

0.882

Attitude b

         

   Use of medicines and drivingc

2.3 (0.9)

2.8 (1.4)

1.9 (0.8)

2.1 (1.1)

< 0.001*

   Consequences of driving under the influence of impairing medicinesd

3.5 (0.9)

4.0 (0.9)

3.4 (0.9)

3.6 (0.8)

< 0.001*

Reported behaviour - change in the frequency of driving

         

   No

42

61.9

64

71.9

79

81.0

120

74.2

0.149

   Yes

 

38.1

 

28.1

 

19.0

 

25.8

 

Reported behaviour - change in the use of driving-impairing medicines

         

   No

38

57.9

65

55.4

75

81.3

118

56.8

0.002*

   Yes

 

42.1

 

44.6

 

18.7

 

43.2

 
  1. aThe percentage refers to within the country
  2. bKnowledge and attitude results presented in terms of mean (standard deviation)
  3. c5-item scale (1 = totally disagree; 2 = disagree; 3 = no opinion; 4 = agree; 5 = totally agree). Totally disagree means that the patient does not perceive any risk of driving under the influence of medicines
  4. d5-item scale (1 = totally disagree; 2 = disagree; 3 = no opinion; 4 = agree; 5 = totally agree). Totally disagree means that patients have a negative opinion on the influence of medicines on driving performance and about the consequences of that behaviour
  5. * p-value < 0.05 considered to be statistically significant. P-value was calculated by means of the Chi-square test.